English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  53284286    線上人數 :  628
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"shao y y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 276-300 / 396 (共16頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-05-26T09:26:51Z Cytotoxic chemotherapy as first-line therapy for advanced non-small-cell lung cancer in Taiwan: Daily practice Lai M.-S.;Cheng A.-L;Chiang C.-J;Chen H.-M;Chih-Hsin Yang;Lee H.-S;Liao B.-C;Shao Y.-Y;Liang Y.-H; Liang Y.-H; Shao Y.-Y; Liao B.-C; Lee H.-S; CHIH-HSIN YANG; Chen H.-M; Chiang C.-J; Cheng A.-L; Lai M.-S.
臺大學術典藏 2020-05-25T07:35:28Z Gefitinib or erlotinib in the treatment of advanced non-small cell lung cancer. Shao Y.Y; Chia-Chi Lin; Yang C.H.
臺大學術典藏 2020-05-25T07:35:10Z A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma Yang S.-H; Shao Y.-Y; Chia-Chi Lin; Kuo S.-H; Cheng A.-L; Yeh K.-H.
臺大學術典藏 2020-05-25T06:52:03Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Cheng A.-L.; Lin C.-H; Chang K.-J; Kuo W.-H; Hsu C; Lee W.-C; Liau J.-Y; Huang C.-S; Shao Y.-Y;Kuo K.-T;Hu F.-C;Yen-Shen Lu;Huang C.-S;Liau J.-Y;Lee W.-C;Hsu C;Kuo W.-H;Chang K.-J;Lin C.-H;Cheng A.-L.; Shao Y.-Y; Kuo K.-T; Hu F.-C; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:51:58Z The impact of diabetes mellitus on prognosis of early breast cancer in Asia Lai M.-S.;Cheng A.-L;Kuo R.N.C;Chen H.-M;Yen-Shen Lu;Lin Z.-Z;Shau W.-Y;Shao Y.-Y;Chen W.-W; Chen W.-W; Shao Y.-Y; Shau W.-Y; Lin Z.-Z; YEN-SHEN LU; Chen H.-M; Kuo R.N.C; Cheng A.-L; Lai M.-S.
臺大學術典藏 2020-05-25T06:51:58Z Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma Cheng A.-L.;Hsu C.-H;Shen Y.-C;Huang C.-C;Yen-Shen Lu;Hsiao C.-H;Lee K.-D;Hsu C;Lin Z.-Z;Shao Y.-Y; Shao Y.-Y; Lin Z.-Z; Hsu C; Lee K.-D; Hsiao C.-H; YEN-SHEN LU; Huang C.-C; Shen Y.-C; Hsu C.-H; Cheng A.-L.
臺大學術典藏 2020-05-25T06:51:45Z Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS Chiu H.-H;Liao H.-W;Shao Y.-Y;Yen-Shen Lu;Lin C.-H;Tsai I.-L;Kuo C.-H.; Chiu H.-H; Liao H.-W; Shao Y.-Y; YEN-SHEN LU; Lin C.-H; Tsai I.-L; Kuo C.-H.
臺大學術典藏 2020-04-28T07:25:28Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.; Shen Y.-C.; CHIH-HUNG HSU; Chih-Hung Hsu;Shen Y.-C.;Lin Z.-Z.;Chen P.-J.;Shao Y.-Y.;Ding Y.-H.;Hsu C.;Cheng A.-L.
臺大學術典藏 2020-04-28T07:25:27Z Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma Shao Y.-Y.;Lin Z.-Z.;Hsu C.;Shen Y.-C.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Shen Y.-C.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏 2020-04-28T07:25:26Z Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy Shao Y.-Y. ;Lu L.-C. ;Cheng A.-L. ;Chih-Hung Hsu; Shao Y.-Y.; Lu L.-C.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏 2020-04-28T07:25:25Z High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy Shao Y.-Y. ;Lin Z.-Z. ;Chen T.-J. ;Hsu C. ;Shen Y.-C. ;Chih-Hung Hsu ;Cheng A.-L.; Shao Y.-Y.; Lin Z.-Z.; Chen T.-J.; Hsu C.; Shen Y.-C.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏 2020-04-28T07:25:20Z Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy Shao Y.-Y.;Wu C.-H.;Lu L.-C.;Chan S.-Y.;Ma Y.-Y.;Yen F.-C.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Wu C.-H.; Lu L.-C.; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏 2020-04-28T07:25:20Z Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases Shao Y.-Y.;Ho M.-C.;Cheng A.-L.;Chih-Hung Hsu; Shao Y.-Y.; Ho M.-C.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏 2020-04-28T07:25:20Z Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy Lu L.-C.;Shao Y.-Y.;Chan S.-Y.;Chih-Hung Hsu;Cheng A.-L.; Lu L.-C.; Shao Y.-Y.; Chan S.-Y.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏 2020-04-28T07:25:19Z Clinical activity of metronomic chemotherapy in liver cancers Shao Y.-Y.;Cheng A.-L.;Chih-Hung Hsu; Shao Y.-Y.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏 2020-04-28T07:25:18Z Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer Chow L.-P.; Feng W.-C.; Ho W.-C.; Tsai M.-H.; Shao Y.-Y.; CHIH-HUNG HSU; Yeh C.-C.; Yeh C.-C.;Chih-Hung Hsu;Shao Y.-Y.;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Chow L.-P.
臺大學術典藏 2020-04-28T07:25:15Z Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma Shao Y.-Y.;Liu T.-H.;Lee Y.-H.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Liu T.-H.; Lee Y.-H.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏 2020-04-28T07:25:14Z National policies fostering hospice care increased hospice utilization and reduced the invasiveness of end-of-life care for cancer patients Shao Y.-Y.;Hsiue E.H.-C.;Chih-Hung Hsu;Yao C.-A.;Chen H.-M.;Lai M.-S.;Cheng A.-L.; Shao Y.-Y.; Hsiue E.H.-C.; CHIH-HUNG HSU; Yao C.-A.; Chen H.-M.; Lai M.-S.; Cheng A.-L.
臺大學術典藏 2020-04-28T07:25:14Z Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study Lu L.-C.;Chen P.-J.;Yeh Y.-C.;Chih-Hung Hsu;Chen H.-M.;Lai M.-S.;Shao Y.-Y.;Cheng A.-L.; Lu L.-C.; Chen P.-J.; Yeh Y.-C.; CHIH-HUNG HSU; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏 2020-04-28T07:25:13Z High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma Shao Y.-Y.;Lin H.;Li Y.-S.;Lee Y.-H.;Chen H.-M.;Cheng A.-L.;Chih-Hung Hsu; Shao Y.-Y.; Lin H.; Li Y.-S.; Lee Y.-H.; Chen H.-M.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏 2020-04-28T07:25:13Z Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy Shao Y.-Y.; Shao Y.-Y.;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Chih-Hung Hsu;Wang M.-J.;Cheng A.-L.;Hsu C.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; CHIH-HUNG HSU; Wang M.-J.; Cheng A.-L.; Hsu C.
臺大學術典藏 2020-04-28T07:25:13Z Right or left? Side selection for a totally implantable vascular access device: A randomised observational study Shao Y.-Y.; Hsu M.-C.; Lin W.-Y.;Lin C.-P.;Chih-Hung Hsu;Lee Y.-H.;Lin Y.-T.;Hsu M.-C.;Shao Y.-Y.; Lin W.-Y.; Lin C.-P.; CHIH-HUNG HSU; Lee Y.-H.; Lin Y.-T.
臺大學術典藏 2020-04-28T07:25:11Z Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure Liu T.-H.; CHIH-HUNG HSU; Shao Y.-Y.; Liu T.-H.;Chih-Hung Hsu;Shao Y.-Y.
臺大學術典藏 2020-04-28T07:25:08Z A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy Lin Z.-Z.;Chen B.-B.;Hung Y.-P.;Huang P.-H.;Shen Y.-C.;Shao Y.-Y.;Chih-Hung Hsu;Cheng A.-L.;Lee R.-C.;Chao Y.;Hsu C.; Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; CHIH-HUNG HSU; Cheng A.-L.; Lee R.-C.; Chao Y.; Hsu C.
臺大學術典藏 2020-04-10T12:51:19Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Hsu C.-H.;Shen Y.-C.;Lin Z.-Z.;Chen P.-J.;Shao Y.-Y.;Ding Y.-H.;Chiun Hsu;Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Chiun Hsu; Cheng A.-L.

顯示項目 276-300 / 396 (共16頁)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
每頁顯示[10|25|50]項目